Catalyst Financial Partners’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$400K Buy
1,027
+18
+2% +$7.61K 0.04% 263
2026
Q1
$477K Buy
1,009
+45
+5% +$22.7K 0.06% 214
2025
Q4
$450K Buy
964
+13
+1% +$6.04K 0.05% 194
2025
Q3
$405K Buy
951
+25
+3% +$9.69K 0.05% 198
2025
Q2
$355K Buy
926
+54
+6% +$19.5K 0.04% 210
2025
Q1
$301K Buy
872
+36
+4% +$11.6K 0.06% 216
2024
Q4
$251K Buy
836
+15
+2% +$5.24K 0.05% 234
2024
Q3
$334K Sell
821
-63
-7% -$23.1K 0.07% 188
2024
Q2
$284K Buy
884
+67
+8% +$21.8K 0.06% 194
2024
Q1
$254K Buy
817
+16
+2% +$4.89K 0.07% 194
2023
Q4
$217K Sell
801
-86
-10% -$21.3K 0.06% 203
2023
Q3
$218K Buy
887
+154
+21% +$42.1K 0.07% 185
2023
Q2
$222K Buy
+733
New +$204K 0.08% 175

Other funds holding HCA

Catalyst Financial Partners's HCA Position: Q2 2026 in Review

Catalyst Financial Partners increased its HCA Healthcare (HCA) stake by 1.8% in Q2 2026, buying an estimated $7.61K and bringing the position to 1,027 shares worth $400K. The position accounts for 0.04% of the portfolio, ranked #263.

Catalyst Financial Partners first reported a position in HCA in Q2 2023 and has held it in 13 quarters since. The position peaked at $477K in Q1 2026. 1,333 funds tracked by Wall St. Rank hold HCA as of Q2 2026.

  • Catalyst Financial Partners held 1,027 shares of HCA Healthcare worth $400K as of Q2 2026.
  • Catalyst Financial Partners bought 18 HCA Healthcare shares in Q2 2026, an estimated $7.61K.
  • HCA Healthcare made up 0.04% of Catalyst Financial Partners's portfolio in Q2 2026, its #263 holding.
  • Catalyst Financial Partners first reported a position in HCA Healthcare in Q2 2023 and has held it in 13 quarters since.
  • Catalyst Financial Partners's HCA Healthcare position peaked at $477K in Q1 2026.
  • 1,333 funds tracked by Wall St. Rank held HCA Healthcare as of Q2 2026.

Based on Catalyst Financial Partners's 13F filing for Q2 2026, filed 30 Jul 2026.